Literature DB >> 9669620

Epidemiology of methicillin-resistant Staphylococcus aureus in three Canadian tertiary-care centers.

K Suh1, B Toye, P Jessamine, F Chan, K Ramotar.   

Abstract

OBJECTIVE: To describe the epidemiology and spread of methicillin-resistant Staphylococcus aureus (MRSA) in three tertiary-care centers in Ottawa, Ontario, Canada, where MRSA is encountered infrequently.
DESIGN: Retrospective review over a 6-year period, from January 1, 1990, through December 31, 1995.
SETTING: Three tertiary-care teaching hospitals in Ottawa. PARTICIPANTS: Patients and healthcare workers (HCWs) with MRSA isolated from any body site.
METHODS: Patients and HCWs were identified retrospectively through hospital microbiology and infection control records. Patient charts were reviewed for clinical and epidemiological data, including age, gender, previous hospital admissions (where noted), and current and recent antibiotic use. MRSA isolates that were available were typed using pulsed-field gel electrophoresis (PFGE). Methicillin resistance was confirmed by standard methods and by polymerase chain reaction using mecA-specific primers.
RESULTS: MRSA was identified in 53 patients and 2 HCWs. Three patients were excluded from further analysis because medical records were incomplete. Epidemiological data were collected on the remaining 52 individuals. Thirty-nine isolates from 31 patients and 2 HCWs were available for PFGE typing. Five epidemiologically linked nosocomial clusters involving 10 patients and 2 HCWs were identified and were confirmed by PFGE. MRSA isolates from a sixth cluster were not available for PFGE. In each cluster, nosocomial spread was minimized by standard infection control practices, including strict isolation of patients and screening of contacts. There was no evidence of secondary spread of MRSA involving the remaining 36 patients. Recent antibiotic use, surgery, admission to an intensive-care unit, and previous hospitalization were common among patients. There was no evidence of spread of MRSA among the three hospitals, and no endemic strains were apparent in any of these centers.
CONCLUSIONS: MRSA remains an infrequent isolate in our centers, with no apparent interhospital spread. In institutions with little or no endemic MRSA, rigorous application of standard infection control practices is effective in limiting nosocomial transmission of this organism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9669620     DOI: 10.1086/647838

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  5 in total

1.  Prevalence of methicillin-resistant Staphylococcus aureus in a Canadian inner-city shelter.

Authors:  Tom A Szakacs; Baldwin Toye; Jeffrey M Turnbull; Wendy Muckle; Virginia R Roth
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

2.  Epidemiologic genotyping of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis at a university hospital and comparison with antibiotyping and protein A and coagulase gene polymorphisms.

Authors:  I Montesinos; E Salido; T Delgado; M Cuervo; A Sierra
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance.

Authors:  A E Simor; M Ofner-Agostini; E Bryce; K Green; A McGeer; M Mulvey; S Paton
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

4.  Evaluation of the IDI-MRSA assay for detection of methicillin-resistant staphylococcus aureus from nasal and rectal specimens pooled in a selective broth.

Authors:  M Desjardins; Christiane Guibord; B Lalonde; B Toye; K Ramotar
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.

Authors:  Guadalupe Miranda-Novales; Blanca E Leaños-Miranda; Mariano Vilchis-Pérez; Fortino Solórzano-Santos
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-10-12       Impact factor: 3.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.